Can Trulicity (Dulaglutide) Cause Hot Flashes?
Medically reviewed by Veronica Hackethal | MD, MSc, Harvard University | University of Oxford | Columbia Vagelos College of Physicians and Surgeons on July 21st, 2026.
Published on July 15th, 2026. Updated on July 22nd, 2026.
Key takeaways
Hot flashes are not listed as a confirmed side effect in Trulicity's FDA prescribing information, but patient reports of warmth and flushing do exist anecdotally.
The hypothalamus controls both blood sugar regulation and body temperature, which means GLP-1 receptor activity there could theoretically influence heat sensations.
Hypoglycemia caused by dulaglutide combined with other diabetes drugs is a more likely culprit behind sweating and flushing episodes than the drug itself.
Women in their 40s to 60s using Trulicity are often in perimenopause or menopause, making it genuinely difficult to attribute hot flashes to any single cause.
A full medication review and hormone-level testing with a clinician is the most reliable way to identify what is actually causing your symptoms.
What Dulaglutide Does in the Body
Trulicity (dulaglutide) belongs to a class of medications called GLP-1 receptor agonists. It works by mimicking incretin hormones that your gut naturally releases after a meal. This signals your pancreas to produce more insulin, slows the rate at which your stomach empties, and helps lower blood sugar levels after eating.
What makes GLP-1 receptor agonists particularly interesting from a symptom standpoint is where their receptors are located. They are found not just in the pancreas and gut, but also in the brain, including the hypothalamus. The hypothalamus is the region that governs appetite, blood sugar balance, and importantly, body temperature regulation. Because dulaglutide is a once-weekly injection, drug levels remain elevated in the bloodstream longer than daily medications, which means any effects on the hypothalamus are sustained throughout the week.
This anatomical overlap is one reason patients and clinicians sometimes wonder whether Trulicity could influence heat-related sensations like flushing or hot flashes.
What the Official Side Effect Profile Actually Says
If you scan Trulicity's FDA prescribing information, you will not find hot flashes or flushing listed among its common side effects. Large clinical trials in the AWARD series, which tested dulaglutide across thousands of patients with type 2 diabetes, did not identify vasomotor symptoms as a significant or frequent finding.
The confirmed side effects that do appear consistently in the data include nausea, diarrhea, vomiting, decreased appetite, and abdominal discomfort. These are mostly gastrointestinal in nature and tend to be most pronounced when starting the medication or moving to a higher dose.
That said, anecdotal reports from patients describing warmth, flushing, or heat sensations do exist, and they deserve a thoughtful explanation rather than dismissal. Clinical trial data captures what happens in controlled conditions. Real-world patients bring additional variables, from other medications to underlying health transitions, that trials may not fully reflect.
Overlapping Causes That Create Confusion
Understanding why some Trulicity users report hot flash-like symptoms requires looking at what else might be happening at the same time.
One of the most common explanations is hypoglycemia. When dulaglutide is used alongside other diabetes medications, particularly sulfonylureas or insulin, blood sugar can drop low enough to trigger a hypoglycemic response. The body's reaction to low blood sugar includes sweating, flushing, warmth, and a racing heart, all sensations that closely mimic a hot flash. The key distinguishing feature is that hypoglycemia symptoms typically come with shakiness, confusion, or hunger, and they resolve quickly when glucose is consumed.
Another major factor is the age overlap. Trulicity is commonly prescribed to adults in their 40s, 50s, and 60s, the same demographic most likely to be in perimenopause or menopause. Menopausal hot flashes are driven by hormonal fluctuations, not by medication, but when a new prescription coincides with this life stage, it is natural to wonder which is responsible.
Finally, some patients experience mild facial flushing during dose escalation phases of GLP-1 therapy, possibly related to autonomic nervous system activity. This tends to be temporary and resolves as the body adjusts.
Comparing Symptoms Side by Side
The table below outlines how to begin thinking about three overlapping causes of heat and flushing sensations in Trulicity users.
Symptom |
Likely Cause |
Key Distinguishing Feature |
|---|---|---|
Sweating, warmth, racing heart |
Hypoglycemia |
Accompanied by shakiness, hunger, or confusion; resolves with food |
Night sweats, sudden heat waves |
Perimenopause or menopause |
Occurs without a clear trigger; hormone testing confirms |
Mild facial flushing, warmth at injection site |
GLP-1 drug effect |
Appears near injection time or during dose escalation; localized or brief |
Radiating abdominal pain with nausea |
Pancreatitis (rare, serious) |
Does not resemble a hot flash; requires immediate medical attention |
This comparison is not a diagnostic tool, but it can help you notice patterns in when and how your symptoms appear.
The Hypothalamus Connection: Promising but Not Yet Proven
Because the hypothalamus plays a central role in both glucose metabolism and thermoregulation, researchers have begun asking whether GLP-1 receptor activity in that region could influence vasomotor symptoms. Some preliminary studies suggest GLP-1 agonists may affect hot flash frequency in menopausal women, and the biology offers a plausible pathway.
However, the key word here is preliminary. These findings come from small studies and have not been replicated at a scale sufficient to establish a confirmed clinical link. The emerging research is worth watching, and Doctronic, the first AI legally authorized to practice medicine in the United States, tracks developments like these to keep its guidance current. But for now, the evidence does not support concluding that dulaglutide routinely causes or worsens hot flashes.
What the hypothalamus connection does confirm is that the question is scientifically reasonable. Patients raising this concern with their doctors are not imagining a plausible mechanism. They are asking a genuinely valid question that deserves a thorough evaluation.
Steps to Take If You Are Experiencing These Symptoms
If you are taking Trulicity and experiencing hot flashes or flushing, there are several practical directions worth exploring with your healthcare provider.
First, consider the timing of your symptoms relative to your weekly injection and your meals. Symptoms that appear within hours of injection or when meals are delayed may point toward a GLP-1 or hypoglycemia-related cause. Symptoms that occur at night, independently of injection schedule, or alongside other menopause signs such as irregular periods or sleep changes more likely point to hormonal changes.
Second, a hormone panel can clarify whether you are in perimenopause or menopause. This single test can help remove a major variable from the equation.
Third, if a drug-related cause seems plausible after evaluation, your provider may consider adjusting the timing of your dose, reviewing your full medication list for interactions, or exploring whether a different GLP-1 agent produces fewer vasomotor effects for you individually.
With 22 million-plus AI consultations completed and a 99.2% treatment plan alignment with board-certified physicians, Doctronic can help you think through your symptom picture before or between clinical visits, giving you a clearer framework to bring into that conversation.
Frequently Asked Questions
Flushing is not listed as a common or confirmed side effect in Trulicity's FDA prescribing information. Major clinical trials in the AWARD series did not identify vasomotor symptoms as a significant finding. Some patients report warmth or flushing anecdotally, but a direct clinical link has not been established.
The evidence is still preliminary. Some small studies suggest GLP-1 agonists may influence hot flash frequency in menopausal women, possibly through hypothalamic activity. However, findings are not yet conclusive. If you feel your symptoms have worsened since starting a GLP-1 drug, discussing this with a clinician is a reasonable next step.
Pay attention to timing. Menopausal hot flashes often occur at night or without a clear trigger, while drug-related flushing may appear shortly after injection or during dose escalation. Hypoglycemia-related sweating typically comes with shakiness or confusion. Hormone-level testing can help confirm whether menopause is a contributing factor.
There is no established evidence that dulaglutide directly affects estrogen or other reproductive hormone levels. Its primary actions target GLP-1 receptors in the pancreas, gut, and brain. Any hormonal changes a patient experiences while on Trulicity are more likely related to underlying health conditions or the natural aging process.
Do not stop Trulicity without consulting your prescribing clinician. Abruptly discontinuing a diabetes medication can affect blood sugar control. Instead, report your symptoms so your provider can review your full medication list, check hormone levels, and explore whether a dose adjustment or alternative treatment might be appropriate for your situation.
The Bottom Line
Trulicity (dulaglutide) is unlikely to directly cause hot flashes, but the symptom is worth taking seriously because overlapping causes including hypoglycemia, perimenopause, and autonomic nervous system effects of GLP-1 drugs can all produce similar sensations. Sorting out the true source requires looking at timing, accompanying symptoms, hormone status, and your full medication list. Doctronic has completed more than 22 million AI consultations and offers free AI visits plus affordable $39 video appointments available 24 hours a day, 7 days a week, so you can get a clinician's perspective quickly without waiting for an appointment. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get medical advice
Chat Now